More than a decade after TENOR I, substantial disease burden, including high rates of comorbidities, allergic sensitization, poorly controlled asthma, and exacerbations were observed in patients with severe or difficult-to-treat asthma in TENOR II, despite standard-of-care therapy.
http://ift.tt/2uBnS0h
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου